CRE Strategies Could Help Preserve Value in Life Sciences Mergers & Acquisitions

Summary

While pharmaceutical companies acquire sponsor-backed biotech companies, corporate real estate teams are becoming more responsible for preserving the value of those deals, according to a new CBRE insight.

Even as acquired biotech firms tend to have smaller real estate footprints and leaner workforces, they become only partially integrated after the deal closes.